BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4085521)

  • 1. The metabolic fate of 11-bromo[15-3H]vincamine in man.
    Mayo BC; Biggs SR; Hawkins DR; Chasseaud LF; Darragh A; Leaf FC
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):189-96. PubMed ID: 4085521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolism of vincamine in the rat].
    Viganò V; Paracchini S; Piacenza G; Pesce E
    Farmaco Sci; 1978 Aug; 33(8):583-94. PubMed ID: 744256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic fate of 11-bromo-[15-3H] vincamine in rats, dogs and humans.
    Mayo BC; Biggs SR; Hawkins DR; Chasseaud LF; Darragh A; Baldock GA; Whitby BR
    J Pharmacobiodyn; 1982 Dec; 5(12):951-64. PubMed ID: 7169608
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of vincamine in the rat in vivo and in vitro.
    Vereczkey L; Tamás J; Czira G; Szporny L
    Arzneimittelforschung; 1980; 30(11):1860-5. PubMed ID: 7192994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of 11-bromovincamine in human plasma by high-performance liquid chromatography.
    Brodie RR; Chasseaud LF
    J Chromatogr; 1982 Mar; 228():413-7. PubMed ID: 7076771
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma concentrations and renal excretion of vincamine after oral administration in man (author's transl)].
    Siegers CP; Iven H; Strubelt O
    Arzneimittelforschung; 1977; 27(6a):1271-4. PubMed ID: 578451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
    Millart H; Lamiable D; Houin G; Plat M; Choisy H; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of vincamine teprosilate.
    Cadórniga R; Saiz Vadillo MC; Molina IT; Cadórniga L
    Int J Clin Pharmacol Res; 1984; 4(4):281-90. PubMed ID: 6500775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinetic behavior of 3H-vincamine in man. Compartmental analysis].
    Camón L; Rodríguez Farré E; Valdecasas FG
    Arch Farmacol Toxicol; 1978 Apr; 4(1):39-40. PubMed ID: 697401
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of 3H-enisoprost, a gastric antisecretory prostaglandin, in healthy humans.
    Allan LM; Hawkins AJ; Vose CW; Firth J; Brownsill RD; Steiner JA
    Xenobiotica; 1987 Oct; 17(10):1233-46. PubMed ID: 3424870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biopharmaceutics of vincamine salts after oral administration in humans].
    Aiache JM; Turlier M; Sibaud Y
    Farmaco Prat; 1985 Mar; 40(3):87-100. PubMed ID: 3996561
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the vincamine-papaverine association. i. biochemical investigations.
    Costrini R; Galzigna L; Bianchi M; Nunziata A; Cattani L
    Agressologie; 1978; 19(3):211-4. PubMed ID: 736220
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relative bioavailability of a vincamine retard formulation. Pharmacokinetic study in normal subjects (author's transl)].
    Erking W; Lücker PW; Metz G; Specker M; Wetzelsberger K
    Arzneimittelforschung; 1978; 28(12):2332-6. PubMed ID: 582951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic fate of 3[H]econazole in man.
    Midgley I; van Bladeren PJ; Hawkins DR; Chasseaud LF; Darragh A; Brodie RR; Walmsley LM
    Xenobiotica; 1981 Sep; 11(9):595-608. PubMed ID: 7314642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic determination of vincamine.
    Pietta P; Rava A; Catenacci E
    J Chromatogr; 1981 May; 210(1):149-53. PubMed ID: 7251726
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of vincamine and related compounds.
    Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):89-103. PubMed ID: 3899662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic evidence for passage of vincamine through the blood-brain barrier.
    Sprumont P; Lintermans J
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):42-8. PubMed ID: 485685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of vincamine in human plasma using automated high-performance liquid chromatography.
    Dubruc C; Caqueret H; Bianchetti G
    J Chromatogr; 1981 Jan; 204():335-9. PubMed ID: 7217262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutic and pharmacokinetic aspects of vincamine HCl.
    Ritschel WA; Agrawala P
    Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):129-36. PubMed ID: 4010386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.